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Low-phenylalanine diet, the mainstay of treatment for phenylketonuria (PKU), has
been shown to increase glycemic index and glycemic load, affecting the availability
of substrates for microbial fermentation. Indeed, changes in the PKU gut microbiota
compared with healthy controls have been previously reported. In this study we
compared the gut microbial communities of children with PKU and with mild
hyperphenylalaninemia (MHP, unrestricted diet). For each group, we enrolled 21 children
(4–18 years old), for a total dataset of 42 subjects. We assessed dietary intake and
performed gut microbiota analysis by sequencing the V3–V4 hypervariable regions of the
16S rRNA gene. Short chain fatty acids (SCFAs) were quantified by gas chromatographic
analysis. While alpha-diversity analysis showed no significant differences between PKU
and MHP groups, microbial community analysis highlighted a significant separation of
the gut microbiota according to both unweighted (p = 0.008) and weighted Unifrac
distances (p = 0.033). Major differences were seen within the Firmicutes phylum.
Indeed, PKU children were depleted in Faecalibacterium spp. and enriched in Blautia
spp. and Clostridium spp (family Lachnospiraceae). We found a divergent response of
members of the Firmicutes phylum with respect to daily glycemic index, higher in PKU
children. Faecalibacterium prausnitzii, unclassified Ruminococcaceae and, to a lesser
extent Roseburia spp. negatively correlated with glycemic index, whereas unclassified
Lachnospiraceae were positively associated. Indicator species analysis suggested F.
prausnitzii be related to MHP status and Ruminococcus bromii to be associated with
PKU. Despite PKU children having a higher vegetable and fiber intake, resembling
a vegan diet, their gut microbial profile is different from the microbiota reported in
the literature for individuals consuming a high-fiber/low-protein diet. Indeed, beneficial
microorganisms, such as F. prausnitzii, considered a biomarker for a healthy status and
one of the main butyrate producers, are depleted in PKU gut microbiota. We suggest
that both the quality and quantity of carbohydrates ingested participate in determining
the observed Firmicutes shifts on the PKU population.
Keywords: phenylketonuria, mild hyperphenylalaninemia, diet, microbiota, glycemic index, Faecalibacterium
prausnitzii, butyrate
Bassanini et al. PKU Diet Affects Gut Microbiota
INTRODUCTION
Phenylketonuria (PKU; OMIM 261600) is an inherited metabolic
disorder caused by a mutation in the phenylalanine hydroxylase
enzyme (PAH), which converts phenylalanine (Phe) into
tyrosine. As PAH activity is hampered, phenylalanine
accumulates in the blood and becomes toxic to the brain
(Williams et al., 2008). Allelic heterogeneity at PAH locus
results in a variety of metabolic phenotypes, ranging from mild,
moderate and classical PKU (blood Phe levels >360 µmol/L) to
mild hyperphenylalaninemia (MHP, blood Phe levels ranging
120–360 µmol/L; Güttler and Guldberg, 1996).
Untreated PKU leads to neurodevelopmental damage and
behavioral problems that are preventable by early diagnosis and
dietary treatment (van Spronsen et al., 2017).
A PKU diet, started in the neonatal period and followed life-
long, is characterized by low-protein natural foods (vegetables,
fruits) and special low-protein products, which are low-protein
variants of some foods (bread, pasta, and biscuits; Giovannini
et al., 2012). Adequate protein intake is guaranteed by Phe-
free amino acid mixtures (AAM) with a balanced content of
amino acids and micronutrients. Despite improvements in taste,
the palatability of such formulas is still less than optimal, often
resulting in poor acceptance by school-aged patients. Moreover,
a PKU diet has been shown to increase glycemic index and
glycemic load (Moretti et al., 2017), probably due to special
low-protein products frequently being enriched in sugars.
Considering the crucial role of diet in shaping the
gut microbiota, i.e., the microbial community inhabiting
gastrointestinal tract (Albenberg and Wu, 2014), it is not
surprising that such a peculiar diet leads to microbial
changes in phenylketonuric patients (Pinheiro de Oliveira
et al., 2016; Verduci et al., 2018). Alterations in the gut
microbiota, in turn, may influence gastrointestinal homeostasis,
predispose to chronic inflammation and modulate other
metabolic functions through gut-liver axis and gut-brain axis
(Nieuwdorp et al., 2014).
Up to date, only a study by Pinheiro de Oliveira et al. (2016)
has investigated by 16S rRNA sequencing the gut community
of PKU patients. However, the small cohort (eight patients vs.
ten healthy controls) and the presence of confounding factors
(i.e., antibiotic treatment, age <1 year) might have mitigated the
observed microbial alterations within the gut. Moreover, whether
reported changes in the gut microbiota represent an effect of the
disease itself or a consequence of the modified diet is still unclear.
To this end, this work aims at elucidating, by comparing the
microbiota of PKU children with mild hyperphenylalaninemia,
the role of the low-Phe diet as potential inducer of
microbial dysbiosis.
MATERIALS AND METHODS
Subject Recruitment and Sampling
A total of 42 children (21 PKU/21 MHP) were enrolled in the
study at the Pediatric Department of San Paolo Hospital inMilan,
Italy (Verduci et al., 2018). Inclusion criteria were: gestational
age 37–42 week inclusive, Caucasian, living in Northern Italy,
birth weight ≥2,500 g, single birth, diagnosis of PKU or MHP
due to PAH deficiency. Exclusion criteria were: congenital
malformation, endocrine disorders, chronic liver diseases,
chronic or acute intestinal diseases, treatments with antibiotic,
and probiotic/prebiotic (including glycomacropeptide) in the 3
months preceding the study. All PKU subjects started the diet
therapy at disease diagnosis, usually within 10 days from birth.
Blood phenylalanine concentration was monthly monitored
by the Guthrie test (Guthrie and Susi, 1963).
From all subjects we collected: anthropometric data (height,
weight and z-score body mass index), dietary habits and stool
samples, stored at−80◦C until use. Three-days food diaries were
filled out by a parent for each enrolled subject and processed by
dieticians to calculate the average amounts of energy and nutrient
intake (carbohydrates, soluble and insoluble fibers, lipids,
proteins) using a commercially available software (MetaDieta R©,
Software version 3.1, ME.TE.DA S.r.l., San Benedetto del Tronto,
Italy). For each meal, the glycemic index (GI) value and glycemic
load (GL) were calculated as described by Verduci et al. (2018)
using the following formulas:
GImeal = (
∑
i=1 ,...,n GIfood i
∗ grams of
carbohydratesfood i)/total grams of carbohydratesmeal
GIdaily = (
∑
i=1 ,...,n GImeal i
∗ grams of
carbohydratesmeal i)/daily total grams of carbohydrates
GLmeal =
∑
i=1,...,n GLfood i.
Gut Microbiota Analysis
Fecal DNA extraction was performed using the Spin stool
DNA kit (Stratec Molecular, Berlin, Germany), according to
manufacturer’s instructions. For each sample, 25 ng of extracted
DNA was used to construct the sequencing library. The V3–V4
hypervariable regions of the bacterial 16S rRNA were amplified
with a two-step barcoding approach according to the Illumina
16S Metagenomic Sequencing Library Preparation (Illumina,
San Diego, CA, USA). For library preparation, DNA samples
were amplified with dual-index primers using a Nextera XT
DNA Library Preparation Kit (Illumina). Library concentration
and quantification were determined using a KAPA Library
Quantification Kit (Kapa Biosystems, Woburn, MA, USA) and
Agilent 2100 Bioanalyzer System (Agilent, Santa Clara, CA,
USA), respectively. The libraries were pooled and sequenced with
a MiSeq platform (Illumina) for 2 × 250 base paired-end reads
and a total of 2.5 Gbases raw reads were obtained.
Fecal Metabolite Measurement
We performed short chain fatty acids (SCFAs) and calprotectin
quantification from stool samples.
Concentrations of acetic, propionic, iso-butyric, butyric, and
iso-valeric acids were assessed by gas liquid chromatography
in accordance with the method proposed by Weaver et al.
(1989) with slight modifications described in Borgo et al. (2017).
Analyses were performed using a Varian model 3400 CX Gas-
chromatograph fitted with FID detector, split/splitless injector
and a SPB-1 capillary column (30m× 0.32mm ID, 0.25µm film
thickness; Supelco, Bellefonte, PA, USA). Results are expressed
as mg/g of wet weight of feces. Quantification of the SCFAs
was obtained through calibration curves of acetic, propionic,
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iso-butyric, butyric, and iso-valeric acid in concentrations
between 0.25 and 10mM (10mM 2-ethylbutyric acid as internal
standard). SCFA data on the same cohort have been previously
described in Verduci et al. (2018).
Fecal calprotectin concentrations were measured
by a commercial ELISA kit (Calprotectin ELISA Kit,
Immundiagnostik, Bensheim, Germany), according to
manufacturer instructions.
Absolute Quantification of
Methanobrevibacter smithii
Real-time PCR was carried out using a SYBRGreen
chemistry (ThermoScientific, USA) and the specific
primers for Methanobrevibacter smithii (MSfw: 5′-
CCGGGTATCTAATCCGGTTC-3′ and MSrev: 5′-
CTCCCAGGGTAGAGGTGAAA-3′), as previously described
(Borgo et al., 2017). The following thermal cycling parameters
were used for amplification of DNA: 95◦C for 10min followed by
40 cycles of 15 s at 95◦C, 30 s at 60◦C, and 30 s at 72◦C. A melting
curve analysis was also performed to verify amplicon specificity.
The control strain M. smithii DSM-861 (DSM: Deutsche
Sammlung von Mikroorganismen und Zellkulturen,
Braunschweig, Germany) was used for the standard curve.
Microbiota Profiling
The 16S rRNA gene paired sequences obtained were merged
using Pandaseq (release 2.5; Masella et al., 2012), then reads were
filtered by trimming stretches of 3 or more low-quality bases
(quality <3) and discarding the trimmed sequences whenever
they were shorter than 75% of the original one. Bioinformatic
analyses were conducted using the QIIME pipeline (release 1.8.0;
Caporaso et al., 2010), clustering filtered reads into Operational
Taxonomic Unit (OTUs) at 97% identity level and discarding
singletons (i.e., OTUs having only 1 supporting read along
the whole dataset) as possible chimeras. Taxonomic assignment
TABLE 1 | Cohort characteristics and dietary habits.
MHP (n = 21) PKU (n = 21) p-value
Female 12 11
Male 9 10
Age (years) 8.0 ± 3.4 10.0 ± 3.5 0.060
BMI z-score 0.2 ± 1.0 0.5 ± 1.1 0.310
Blood Phe levels (mmol/L) 228.0 ± 87.1 262.6 ± 97.5 0.241
Carbohydrate (% energy) 56.0 ± 5.9 61.0 ± 7.0 0.047 *
Fiber (overall grams) 8.9 ± 2.6 16.0 ± 9.1 0.003 **
Protein (% energy) 52.1 ± 11.1 43.2 ± 15.1 0.023 *
Lipids (% energy) 32.6 ± 4.7 29.6 ± 6.6 0.188
Glycemic index (GI) 52.8 ± 3.8 65.1 ± 5.2 <0.001 ***
Glycemic load (GL) 104.1 ± 29.8 163.5 ± 48.6 <0.001 ***
Values are expressed as mean ± standard deviation; one asterisk (*) indicates p-
value smaller than 0.05 (p < 0.05), two asterisks (**) indicate p-value smaller than
0.01 (p < 0.01), three asterisks(***) indicate p-value smaller than 0.001 (p<0.001;
Mann-Whitney U-test).
was performed via the RDP classifier (Wang et al., 2007)
against the Greengenes database (ftp://greengenes.microbio.me/
greengenes_release/gg_13_8_otus).
Indicator species analysis was performed using the
indicspecies package in R (De Cáceres and Legendre, 2009)
on the QIIME-derived OTU table.
Alpha-diversity was computed using the Chao1, number of
OTUs, Shannon diversity, and Faith’s Phylogenetic Diversity
whole tree (PD whole tree) metrics; statistical evaluation among
alpha-diversity indices was performed by a non-parametric
Monte Carlo-based test, using 9999 random permutations.
Weighted and unweighted UniFrac distances and PERMANOVA
(adonis function) in the R package vegan (version 2.0-10;
Oksanen et al., 2013) were used to compare the microbial
community structure of the PKU and MHP children.
Statistical Analysis
Statistical comparisons were performed usingMATLAB software
(Natick, MA, USA). Comparisons of the two groups were
performed using Student’s t-test for normally distributed
variables and Wilcoxon test for non-normally distributed
variables. For evaluating differences in relative abundances of
bacterial groups, a Mann-Whitney U-test was performed. For
each phylogenetic level, only the 25 most abundant taxa were
considered, in order to focus on the major players of the
gut microbiota. Due to multiple testing, a Benjamini-Hochberg
correction was applied, considering a FDR < 0.15 as significant.
For clarity, uncorrected p-values were reported in the text.
Co-abundance of microbial groups, as well as correlations
between taxa and nutritional values and SCFA quantities were
assessed through Spearman correlation and the associated linear
regression model. Unless otherwise stated, p-values < 0.05 were
considered as significant.
RESULTS
Cohort Description
Cohort characteristics are reported in Table 1. At recruitment,
blood Phe levels in PKU children was slightly higher than the
MHP group (p = 0.24). Compared with MHP children, PKU
children showed higher dietary intakes of carbohydrates and
fibers and a significant lower consume of proteins (expressed as
%). Glycemic index (GI) and glycemic load (GL), evaluated for
each meal, were significantly higher in PKU children compared
with MHP subjects (p < 0.001). Anthropometric measurements
were similar, with a BMI z-score not significantly different in the
two groups (p= 0.31).
Gut Microbiota Composition in PKU and
MHP Children
Five samples (2 PKU and 3 MHP subjects) were excluded from
the analysis due to very low raw read quantities (with an average
of 189 reads compared to an average of 159,914 reads among
the other samples); the final dataset for microbiota analysis, then,
consisted of 37 subjects: 19 PKU and 18 MHP.
To avoid biases related to uneven sequencing depth, samples
were subsampled to 50,000 reads each. After quality filtering
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processes, we obtained a mean count of 49,749 ± 111 reads
per sample.
Alpha-diversity analysis (data not shown) revealed no
significant differences between PKU and MHP groups for any of
the metrics used (number of OTUs, p = 0.306; chao1, p = 0.131;
Shannon, p = 0.894; PD whole tree, p = 0.31). Beta-diversity
analysis, instead, showed that the structure of the PKU fecal
microbiota differed significantly from that of the MHP group
according to both unweighted (p = 0.008) and weighted (p =
0.032) Unifrac distances (β-diversity, Figure 1).
The gut microbiota composition at the phylum and family
levels is depicted in Figure 2 and in Table S1. The most
relatively abundant phyla in PKU and MHP subjects were
Firmicutes and Bacteroidetes, the latter slightly higher in
MHP subjects. Among the most relatively abundant families,
we found Veillonellaceae to be significantly depleted in PKU
children (p = 0.002). Although not statistically significant,
Ruminococcaceae were enriched in MHP and Lachnospiraceae in
PKU subjects.
At the genus level (Figure 3), Faecalibacterium (p = 0.001),
Ruminococcaceae (other) (p = 0.03) were more relatively
abundant in MHP children; although not significant, Bacteroides
and Prevotella genera showed the same trend. Furthermore,
we observed an increased Prevotella/Bacteroides ratio in MHP
compared with PKU (0.14± 0.59; 0.02± 0.05, respectively).
In contrast, PKU children were characterized by a significant
increase in the relative abundance of Blautia (p = 0.004),
Clostridium (belonging to Lachnospiraceae family, p = 0.002),
and Lachnospiraceae (other) (p = 0.019). Significantly altered
taxa belonged to the Firmicutes phylum and are highlighted
in Table 2.
Because of the underestimation of Archaea by 16S rRNA gene
sequencing, Real-time PCR quantification of the most abundant
Archaea species in human gut microbiota, Methanobrevibacter
smithii, was performed. We did not observe significant
differences between PKU and MHP subjects (p= 0.40).
Indicator species analysis highlighted Akkermansia
muciniphila OTU 1045 (best BLAST hit: Accession number
NR_074436.1, with 97% seq. similarity over 420 bp, e-value =
0.046) and Faecalibacterium prausnitzii OTU 3793 (accession
number: NR_028961.1, with 97% seq. similarity over 420 bp,
e-value = 0.001) to be characteristic of MHP microbiota,
whereas Ruminococcus bromii OTU 3232 (accession number:
NR_025930.1, with 97% seq. similarity over 420 bp, e-value =
0.018) to be associated to PKU.
Bacterial Correlation Patterns
Because cross-feeding between species is relevant in gut
microbiota dynamic, we performed correlation analysis to
study interactions between different members of intestinal
microbiota. Several significant bacterial connections (Table S2),
both positive and negative, have been observed. In particular,
MHP indicator species A. muciniphila and F. prausnitzii showed
several interactions with other members of the microbial
community: Akkermansia was negatively related to Unclassified
Lachnospiraceae (R = −0.61) and to Blautia spp. (R =
−0.40), while was positively associated to Oscillospira (R =
0.57) and to Unclassified Clostridiales (R = 0.34). On the
other hand, F. prausnitzii was only found positively related to
Ruminococcaceae (other) genus (R = 0.42). The PKU indicator
species, Ruminococcus bromii, instead, showed no correlation to
other genera itself.
Correlations Between Gut Microbiota and
Nutritional Values
Statistical correlation analysis between diet and microbiota
showed that Faecalibacterium spp., significantly increased in
MHP group, negatively correlated with fiber intake, both soluble
and insoluble fibers (R = −0.61; R = −0.37), and with GI,
GL (R = −0.53 and R = −0.49, respectively). Ruminococcaceae
family as well as its genus Ruminococcaceae (other), with higher
relative abundance among MHP patients (Figure 4), negatively
FIGURE 1 | Beta-diversity analysis in MHP (blue) and PKU (magenta). Principal coordinates analysis (PCoA) of (A) unweighted and (B) weighted Unifrac distances.
Microbial communities are statistically different (adonis test: unweighted p = 0.008, R2 = 0.040; weighted p = 0.033, R2 = 0.058). Second and third principal
coordinates are shown in the plot for both distances.
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FIGURE 2 | Gut microbiota composition in MHP and PKU children. Relative abundance at (A) phylum and (B) family level. All bacterial taxa present at <1% relative
abundance were grouped into the “Other” classification.
FIGURE 3 | Bacterial abundances at genus level. Genera abundances of the 15 most abundant genera are reported as mean proportion along with significant
p-values (two-sided White’s non-parametric t-test) and 95% of confidence interval (bootstrap method).
TABLE 2 | Genera belonging to Firmicutes phylum significantly increased or
depleted in PKU children (Mann-Whitney U-test, p-value <0.05).
Genus MHP
(mean ± SD)
PKU
(mean ± SD)
p-value PKU
Ruminococacceae (other) 7.07 ± 8.26 2.78 ± 4.22 0.030 ↓
Lachnospiraceae (other) 0.35 ± 0.25 1.84 ± 2.52 0.019 ↑
Blautia 1.07 ± 0.85 2.43 ± 2.02 0.004 ↑
Faecalibacterium 8.71 ± 4.32 4.52 ± 4.14 0.001 ↓
Clostridium 0.23 ± 0.29 1.92 ± 2.64 0.002 ↑
Dialister 3.28 ± 3.83 0.67 ± 2.1 0.036 ↓
related with GI and soluble fibers (R = −0.40 and R = −0.49,
respectively), while an opposite trend was observed among the
Lachnospiraceae (other) genus within the same nutritional values
(GI R= 0.43; soluble fibers R= 0.49).Oscillospira, slightly higher
in PKU children, was positively related to energy assumption and
carbohydrates (R = 0.43 and R = 0.47, respectively); Roseburia,
genus enriched in MHP, was found negatively related to soluble
fibers (R = −0.42) and to lipids (R = −0.42). All of these
correlation coefficients were statistically significant (p < 0.05).
SCFAs and Gut Microbiota Correlation
As reported in our previous work (Verduci et al., 2018), a
decrease in total SCFAs and in particular in butyrate production
was observed in PKU children compared with MHP children (p
= 0.044 and p = 0.026, respectively). Although not statistically
significant, acetate (p = 0.161) was also reduced in PKU
group. Propionate and the isoforms iso-butyrate and iso-valerate,
instead, were similar.
Correlation analysis with gut microbiota composition
revealed several significant interactions between the relative
abundance of certain taxa and fecal SCFA concentrations.
Acetate was found negatively related to Coprococcus (R =
−0.42) and to Blautia (R = −0.50), genera enriched in PKU.
Butyrate was found inversely correlated to Lachnospiraceae
(other) (R = −0.41). Propionate was found to positively
correlate to Bacteroides (R = 0.49) and inversely to Unclassified
Lachnospiraceae (R = −0.42) and to Blautia (R = −0.56). The
branched-chain fatty acids iso-butyrate and iso-valerate were
negatively related to Unclassified Lachnospiraceae (R = −0.64,
R = −0.65, respectively), to Clostridium spp. (R = −0.45
and R = −0.46) and to Blautia spp (R = −0.40, only iso-
butyrate) and positively correlated to Akkermansia (R = 0.47
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FIGURE 4 | Correlations between microbiota and dietary information. Heatmap showing Spearman’s correlations between the most abundant microbial genera and
nutritional values. Color intensity represents the degree of association; positive correlations are depicted in blue and negative in magenta.
and R = 0.44). All correlation coefficients were statistically
significant (p < 0.05).
Fecal Calprotectin Concentrations in PKU
and MHP Patients
To investigate whether PKU subjects are chronically inflamed
in the gut, we quantified fecal calprotectin, a recognized
biomarker for gastrointestinal diseases (Pang et al., 2014).
No significant differences were recorded between PKU and
MHP groups (24.8 ± 14.9µg/g and 40.6 ± 28.3µg/g,
p= 0.10, respectively).
CONCLUSIONS AND DISCUSSION
The aim of this study was to investigate the impact of a low-Phe
diet on microbial gut community and its possible consequences
on PKU patient wellbeing. Indeed, according to European
guidelines for PKU management, the recommended diet should
start as early as possible, usually before the age of 10 days, to
prevent neurological damage (Singh et al., 2014; van Spronsen
et al., 2017). This age corresponds to a well-recognized crucial
step in microbiota acquisition and maturation (Dominguez-
Bello et al., 2019) on which environmental factors may have a
profound impact.
To rule out a direct effect of PAH deficiency in microbiota
alteration, subjects with mild hyperphenylalaninemia, under
normal diet, were enrolled as control group.
Bioinformatic analyses revealed several changes in the
microbial taxa inhabiting the PKU gut compared with
MHP subjects, as already suggested by Pinheiro de Oliveira
et al. (2016). Nevertheless, some differences were observed
between their study and ours, mainly ascribable to the
different enrolled control group (healthy children instead
of MHP), the different age range (4 out of their 8 PKU
patients were <2 years-old), the sequencing method used (Ion
Torrent vs. Illumina) and the subjects’ ethnicity (Brazilian
vs. Italians).
In our cohort, the relative abundance of Firmicutes and
Bacteroidetes was similar, with slight decrease of both phyla
in the PKU group. Although not statistically significant, both
Bacteroides and Prevotella, the two main genera belonging
to the Bacteroidetes, were more relatively abundant in MHP
children. While Bacteroides result is not surprising, probably
related to the reduced protein intake (David et al., 2014) in
Phe-free diet, Prevotella is usually associated with increased
fiber intake (De Filippo et al., 2010), typical of the PKU diet.
Similarly, the Prevotella/Bacteroides ratio was slightly higher in
MHP group, in contrast to the common finding of a higher
ratio in strict vegetarians/vegans (Wu et al., 2011; Franco-de-
Moraes et al., 2017). Recently, a high Prevotella/Bacteroides ratio
has been suggested to be associated with an improvement of
glucose response, possibly preventing cardiometabolic diseases
(Sandberg et al., 2018).
The most relevant shifts, however, concerned the Firmicutes
phylum. Indeed, the PKU gut microbiota was enriched in Blautia
spp. and Clostridium spp. and depleted in Faecalibacterium
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spp., as anticipated in our previous work by absolute real-
time PCR quantification (Verduci et al., 2018). As discussed,
it was reasonable to expect that the higher fiber intake in
PKU patients would have increased Faecalibacterium spp.
proliferation, but the relative abundance of this genus showed
an opposite trend. However, as described by Benus et al.
(2010), a fiber-supplemented diet does not necessarily increase
F. prausnitzii and Ruminococcus populations compared with a
normal balanced diet. Moreover, the quality of fibers (Verduci
et al., 2018) as well as the supplementation of some PKU
special low protein products with inulin could also impact the
abundance of these genera.
It is intriguing that the indicator species analysis showed
an association between MHP phenotype and F. prausnitzii, a
known biomarker for health status (Lopez-Siles et al., 2017). In
healthy adults, this bacterial genus commonly represents more
than 5% of the total gut bacterial population (Miquel et al.,
2013) and is one of the major butyrate producers. Butyrate is
considered the main energy source of colonocytes and displays
anti-inflammatory properties in the colonic mucosa (Flint et al.,
2012). A. muciniphila also characterized the MHP gut microbiota
in the indicator species analysis. A. muciniphila, a mucin-
degrading bacterium, is considered a potential probiotic, that is
able to maintain intestinal integrity (Zhai et al., 2018). As already
reported by other authors (Arumugam et al., 2011; Cani and de
Vos, 2017), A. muciniphila is positively associated with members
of the family Ruminococcaceae, probably sharing nutritional
requirements or cross feeding phenomena.
In contrast, PKU microbial communities were characterized
by Ruminococcus bromii, a well-known starch degrader that
belongs to the non-butyrate-forming Ruminococcaceae (Ze et al.,
2012; Kettle et al., 2015).
Overall, in agreement with the lower total fecal SCFAs
content and in particular of butyrate, the PKU gut microbiota
was depleted in butyrate-producing species and enriched in
genera, i.e., Blautia, that are recognized to exert a pro-
inflammatory effect on gut mucosa. Indeed, Blautia spp. has
been demonstrated to induce cytokines secretion, like tumor
necrosis factor alpha (TNF-alpha), involved in immune acute
phase response (Tuovinen et al., 2013).
Moreover, about half of PKU subjects were characterized
by an increase in the relative abundance of Proteobacteria, in
particular Escherichia spp. Proteobacteria is a phylum of Gram-
negative microorganisms whose membrane lipopolysaccharide
is a well-known inducer of innate immune responses
(Hotamisligil, 2006).
As discussed for the phyla Firmicutes and Bacteroidetes, the
enrichment in Proteobacteria observed in PKU children is in
contrast with the reported underrepresentation of this phylum in
children with rural diet, more similar to PKU vegetarian-vegan
diet than MHP, compared with children under Western-diet (De
Filippo et al., 2010).
Although our study did not show any alteration in
calprotectin, a recognized gut inflammation marker, previous
work by our group (Moretti et al., 2017) demonstrated an
increase in the triglyceride glucose index (TyG index) in PKU
children compared with age- and sex-matched healthy controls.
TyG index is considered a marker of low-grade inflammation
and of peripheral insulin resistance (Er et al., 2016). Moretti
et al. (2017) showed in PKU a positive correlation of TyG
index with glycemic load, reinforcing a possible link between
carbohydrate quality and metabolic disorder predisposition.
Indeed, PKU children showed an increased consumption
of fast-absorbing carbohydrates that escape gut microbiota
fermentation (Verduci et al., 2018), resulting in higher GI
and GL.
It is important to note, we also found a divergent
response of the Firmicutes phylum with respect to daily
GI and GL. Most members of the Lachnospiraceae family,
with the exception of Roseburia, were positively correlated
with both indexes (with Blautia as the most relevant genus),
whereas members of Ruminococcaceae family were negatively, in
particular F. prausnitzii.
The quality of carbohydrates ingested by PKU children
might directly affect Faecalibacterium abundance. In accordance
with our data, Fava and colleagues (Fava et al., 2013) showed
that a diet enriched in carbohydrates with a high glycemic
index resulted in a decreased F. prausnitzii abundance in
subjects at-risk of developing a metabolic syndrome. A plausible
explanation is that fast-absorbing carbohydrates do not represent
a suitable substrate for F. prausnitzii growth, commonly
fermenting complex carbohydrates. On the other hand, short
chain carbohydrates represent a good substrate for Blautia spp.
(Egshatyan et al., 2016), which were more relatively abundant in
the PKU group. The Blautia genus encompasses a huge number
of strains with different metabolic capabilities (Eren et al., 2015),
several of them considered to be acetogens. In contrast, we
found an inverse correlation with fecal acetate concentration.
However, this observation is in agreement with recent findings
by Org et al. (2017) that investigated the relationship between
the gut microbiota composition and metabolic disorder traits.
The authors also suggested a positive correlation between Blautia
and body mass index. Indeed, PKU patients, more than MHP
subjects, are at risk for excessive weight gain (Scaglioni et al.,
2004; Rocha et al., 2013; Couce et al., 2018) and insulin resistance
(Moretti et al., 2017; Couce et al., 2018).
The enrichment of PKU low-protein products in simple
sugars, is a consequence of their poor palatability. In the last
few years, the increasing awareness of the health consequences
of PKU diet led to the development of new products
that could implement or complement these formulas. For
example, some companies have made commercially available
products based on glycomacropeptide (GMP). GMP is a
protein derived from cheese whey, rich in specific essential
amino acids and lacking aromatic amino acids (i.e., Phe).
GMP has been recently demonstrated to have prebiotic
properties with beneficial effects on the gut microbiota
(Sawin et al., 2015).
In addition, new formulas enriched in prolonged-release
amino acids have been recently released. Such medical foods,
meant to allow a physiological-like adsorption, are strongly
improved in palatability thanks to the amino acids coating
layer (Giarratana et al., 2018). It still remains to be evaluated
whether an improvement in current free-amino acid formulas,
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 April 2019 | Volume 9 | Article 101
Bassanini et al. PKU Diet Affects Gut Microbiota
as well as increased attention to the management of dietary
carbohydrate quality in PKU diet (with a particular focus
on special low protein products), can rebalance the PKU
microbial community.
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